Table 6.
Prevalence of metabolic syndrome in the type 2 diabetic patients according to their ethnic background
| Ethnic groups | ||||||||
|---|---|---|---|---|---|---|---|---|
| Defining bodies | Sex | n | Brahman | Chhetri | Mongol | Dalit | Newar | *p-value |
| WHO | Total | 860 | 181 (69.3) | 187 (73.9) | 331 (95.1) | 92 (90.2) | 69 (71.1) | <0.001 |
| Male | 470 | 124 (85.5) | 109 (66.9) | 159 (94.1) | 47 (82.5) | 31 (56.4) | <0.001 | |
| Female | 390 | 57 (49.1) | 78 (86.7) | 172 (96.1) | 45 (100.0) | 38 (90.5) | <0.001 | |
| *p-value | <0.001 | <0.010 | >0.050 | <0.010 | <0.001 | |||
| NCEP ATPIII | Total | 884 | 204 (78.2) | 196 (77.5) | 309 (88.5) | 98 (96.1) | 77 (79.4) | <0.010 |
| Male | 462 | 109 (75.2) | 117 (71.8) | 141 (83.4) | 55 (96.5) | 40 (72.7) | <0.010 | |
| Female | 422 | 95 (81.9) | 79 (87.8) | 168 (93.9) | 43 (95.6) | 37 (88.1) | <0.050 | |
| p-value | >0.050 | <0.010 | <0.010 | >0.050 | >0.050 | |||
| IDF | Total | 854 | 178 (68.2) | 214 (84.6) | 296 (85.1) | 82 (80.4) | 84 (86.6) | <0.001 |
| Male | 410 | 87 (60.0) | 124 (76.1) | 120 (71.0) | 37 (64.9) | 42 (76.4) | <0.050 | |
| Female | 444 | 91 (78.4) | 90 (100.0) | 176 (98.3) | 45 (100.0) | 42 (100.0) | <0.001 | |
| p-value | <0.010 | <0.001 | <0.001 | <0.001 | <0.010 | |||
| Harmonized | Total | 972 | 217 (83.1) | 233 (92.1) | 336 (96.6) | 102 (100.0) | 84 (86.6) | <0.001 |
| Male | 518 | 116 (80.0) | 143 (87.7) | 160 (94.7) | 57 (100.0) | 42 (76.4) | <0.001 | |
| Female | 454 | 101 ((87.1) | 90 (100.0) | 176 (98.3) | 45 (100.0) | 42 (100.0) | <0.001 | |
| p-value | >0.050 | <0.010 | >0.050 | ǂ | <0.010 | |||
Values are presented as n (%). *p-values (2-tailed): Chi-square tests were performed to compare the prevalence of MetS between the male and female patients of different ethnic groups (rows) and within the individual ethnic groups (column). ǂNo statistics were computed because metabolic syndrome defined by Harmonized definition is a constant.